Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Key Points Revenue jumped 24.7% to $374.9 million (GAAP) in Q2 2025, driven by same-facility growth and the White Oak acquisition. Non-GAAP earnings per share rose 64.7% year over year, while GAAP EPS ...

Blue Owl Capital shows strong growth and AUM gains, but dilution and a premium valuation raise caution for investors. Find ...

WM Technology, Inc. (NASDAQ: MAPS) Q2 2025 Earnings Call Transcript August 7, 2025 WM Technology, Inc. misses on earnings ...

Year-to-date Net Income has exceeded Adjusted Net Income by $4.1 million, as discrete items have lowered the effective tax ...

GigaCloud Technology Inc. (NASDAQ: GCT) Q2 2025 Earnings Call Transcript August 7, 2025 GigaCloud Technology Inc. beats ...

PG&E Corporation recorded second-quarter 2025 income available for common shareholders of $521 million, or $0.24 per share, ...

Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment.

Separately, the company raised its 2025 target for its Texas Residential Virtual Power Plant (VPP) program from 20 MW to 150 ...